Malaria Treatment FAQ:
Why would a company undergo the costly R&D process for a product for people who don’t have buying power?
Why would a company undergo the costly R&D process for a product for people who don’t have buying power?
December 12, 2008
Pages © All Rights Reserved Malaria Treatment
{ 3 comments… read them below or add one }
good for their reputation
gov’t subsidies (sp?)
tax breaks
and sometimes, if diseases are similar, they can use the research as a stepping stone when something applicable shows up
(I’m sure there are others, this is just what came to mind first)
Because they are testing it on the population. It is more difficult (but not impossible) for them to test it on the US population (they already have). They take drugs that are outdated and sell them to poor countries for a profit. They use drugs that are banned in the US in poorer countries. And yes they can because the FDA does not protect anyone but their own pockets. They suppress natural cures that everyone could afford so that they can make a similar type drug that they can patent and sell for billions.
Nobel Prize winner Joseph Stiglitz has addressed this
lack of financial motivation to develop vaccines and medicines for diseases of the third world which do not attack the profit motivated R & D that is required to solve problems which affect millions around the world.
He calls for a prize money award for companies which provide the vaccines and medicines that apply to the “unprofitable” diseases of the third world.